Inverse correlation between expression of HLA-B and c-myc in uveal melanoma

Journal of Pathology

Volumn 181, Issue 1, 1997, Pages 75-79

  Blom, Derk Jan R ^a,c   Mooy, Cornelia M ^b   Luyten, Gregorius P M ^b   Kerkvliet, Sonja ^b   Ouwerkerk, Ilse ^a   Zwinderman, Aeilko H ^a   Schrier, Peter I ^a   Jager, Martine J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c Department of Ophthalmology ^*  (Netherlands)

Author keywords

c myc; HLA B; uveal melanoma

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; MESSENGER RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NORTHERN BLOTTING; ONCOGENE C MYC; PRIORITY JOURNAL; UVEA MELANOMA;

ADOLESCENT; ADULT; AGED; BLOTTING, NORTHERN; DOWN-REGULATION; FEMALE; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RETROSPECTIVE STUDIES; TUMOR CELLS, CULTURED; UVEAL NEOPLASMS;

EID: 0031039179     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199701)181:1<75::AID-PATH724>3.0.CO;2-V     Document Type: Article

References (26)

1. Garrido F, Ruiz-Cabello F. MHC expression on human tumors - its relevance for local tumor growth and metastasis. Sem Cancer Biol 1991; 2: 3-10.
2. Schrier PI, Peltenburg LTC. Relationship between myc oncogene activation and MHC class I expression. Adv Cancer Res 1993; 60: 181-246.
3. Versteeg R, Krüse-Wolters M, Plomp AC, et al. Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific. J Exp Med 1989; 170: 621-635.
4. Jager MJ, De Wolff-Rouendaal D, Breebaart AC, Ruiter DJ. Expression of HLA antigens in paraffin sections of uveal melanomas. Doc Ophthalmol 1986; 64: 69-76.
5. Natali PG, Bigotti A, Nicotra MR, et al. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies. Cancer Res 1989; 49: 1269-1274.
6. De Waard-Siebinga I, Houbiers JGA, Hilders CGJM, De Wolff-Rouendaal D, Jager MJ. Differential expression of HLA-A and HLA-B alleles on uveal melanoma as determined by immuno-histology. Ocul Inimunvl Inflamm 1996; 4: 1-14.
7. Mooy CM, Luyten GPM, De Jong PTVM, et al. An immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma. Am J Pathol 1995; 147: 1097-1104.
8. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, et al. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 1993; 100: 1389-1398.
9. Stam NJ, Vroom ThM, Peters PJ, Pastoors EB.,Ploegh HL. HLA-A and HLA-B-specific monoclonal antibodies reactive with free heavy chains in Western blots, in formal-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. Int Immunol 1989; 2: 113-125.
10. Stam NJ, Spits H, Ploegh HL, Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterisation of certain HLA-C locus products. J Immunol 1986; 137: 2299-2306.
11. Evan GL, Lewis GK, Ramsay G, Bishop M. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol 1985; 5: 3610-3616.
12. Luyten GPM, Mooy CM, De Jong PTVM, Hoogeveen AT. Luider TM. A chicken embryo model to study the growth of human uveal melanoma. Biochem Biophys Res Commun 1993; 92: 502-509.
13. De Waard-Siebinga I, Blom DJR, Griffioen M, et al. Establishment and characterisation of a uveal melanoma cell line. Int J Cancer 1995; 62: 155-161.
14. Luyten GPM, Naus NC, Mooy CM, et al. Establishment and characterization of primary and metastatic uveal melanoma cell lines. Int J Cancer 1996; 66: 1-8.
15. Feinberg AP. Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 6-13.
16. Colby WW, Chen EY, Smith DH, Levinson AD. Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC 29, Nuture (London) 1983; 301: 722-725.
17. Koller BH. Sidwell B, DeMars R, Orr HT. Isolation of HLA-locus-specific DNA probes from the 3′-untranslated region. Proc Natl Acad Sci USA 1984; 81: 5175-5178.
18. Peltenburg LTC, Dee R, Schrier PI. Down-regulation of HLA class-I expression by c-myc in human melanoma is independent of enhancer A. Nucleic Acids Res 1993; 21: 1179-1185.
19. Jager MJ, Van Der Pol JP, De Woltf-Rouendaal D, De Jong PTVM, Ruiter DJ. Decreased expression of HLA class II antigens on human uveal melanoma cells after in vivo X-ray irradiation. Am J Ophthalmol 1988; 105: 78-86.
20. Carrel S, Schreyer M, Gross N, Zografos L. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma. Anticancer Res 1990; 10: 81-89.
21. Versteeg R, Peltenburg LTC, Plomp AC, Schrier PI. High expression of the c-myc oncogene renders melanoma cells prone to lysis by natural killer cells. J lmmunol 1989; 143: 4331-1337.
22. Peltenburg LTC, Steegenga WT, Krüse KM. Schner PI. c-myc-induced natural killer cell sensitivity of human melanoma cells is reversed by HLA-B27 transfection. Ear J lmmunol 1992; 22: 2737-2740.
23. Ma D, Luyten GP, Luider TM. Niederkorn JY. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model. Invest Ophthalmol Vis Sci 1995; 36: 435-441.
24. Dune FH, Campbell AM, Lee WR. Damato BE. Analysis of lymphocytic infiltration in uveal melanoma. Invest Ophthalmol Vis Sci 1990; 31: 2106-2110.
25. Whelchel JC, Farah SE, McLean IW, Burnier MN. Immunohistochemistry of infiltrating lymphocytes in uveal malignant melanoma. Invest Ophthalmol Vis Sci 1993; 34: 2603-2606.
26. De Waard-Siebinga I, Hilders CGJM, Hansen BE. Delft JL van, Jager MJ. HLA expression and tumor-infiltrating immune cells in uveal melanoma. Graefe's Arch Clin Exp Ophthalmol 1995; 234: 34-42.